Brief: RhoVac Gets FDA Approval In US For Start Of Its Phase IIb Clinical Trial

Chosa Oncology AB

28/02/2020 14:23

Feb 28 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RECEIVES FDA APPROVAL IN US FOR START OF ITS PHASE IIB
CLINICAL
TRIAL
    * RESULTS REPORT ON ACTIVE TREATMENT PART OF STUDY IS
EXPECTED IN
H2 2021

Source text for Eikon:  ID:nWkr7vqLNC 
Further company coverage:  RHOVAC.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))